These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22436542)

  • 21. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
    Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
    Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis.
    Yunfeng G; Weiyang H; Xueyang H; Yilong H; Xin G
    Medicine (Baltimore); 2017 Jul; 96(27):e7368. PubMed ID: 28682886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
    Nilsen TS; Raastad T; Skovlund E; Courneya KS; Langberg CW; Lilleby W; Fosså SD; Thorsen L
    Acta Oncol; 2015 Nov; 54(10):1805-13. PubMed ID: 25927504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
    BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
    Gardner JR; Livingston PM; Fraser SF
    J Clin Oncol; 2014 Feb; 32(4):335-46. PubMed ID: 24344218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect on Bone Outcomes of Home-based Exercise Intervention for Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: A Pilot Randomized Controlled Trial.
    Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song Y; Song H
    Cancer Nurs; 2018; 41(5):379-388. PubMed ID: 28731882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?
    Newton RU; Taaffe DR; Spry N; Cormie P; Chambers SK; Gardiner RA; Shum DH; Joseph D; Galvão DA
    BMC Cancer; 2012 Sep; 12():432. PubMed ID: 23013489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
    Owen PJ; Daly RM; Livingston PM; Fraser SF
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.
    Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Bolam KA; Taaffe DR
    Med Sci Sports Exerc; 2019 Apr; 51(4):607-614. PubMed ID: 30395051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer.
    Harrington JM; Schwenke DC; Epstein DR; Bailey DE
    Oncol Nurs Forum; 2014 Jan; 41(1):21-9. PubMed ID: 24368236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
    Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.
    Newton RU; Christophersen CT; Fairman CM; Hart NH; Taaffe DR; Broadhurst D; Devine A; Chee R; Tang CI; Spry N; Galvão DA
    BMJ Open; 2019 Apr; 9(4):e024872. PubMed ID: 30987986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term impact of androgen-deprivation therapy on physical function and quality of life.
    Alibhai SM; Breunis H; Timilshina N; Naglie G; Tannock I; Krahn M; Warde P; Fleshner NE; Canning SD; Tomlinson G
    Cancer; 2015 Jul; 121(14):2350-7. PubMed ID: 25809861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
    Dhanapal V; Reeves DJ
    J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
    Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
    Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.